ETF Managers Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$46.6K Buy
18,339
+4,490
+32% +$8.87K ﹤0.01% 662
2022
Q4
$25.9K Sell
13,849
-2,341
-14% -$5.84K ﹤0.01% 506
2022
Q3
$42K Sell
16,190
-1,022
-6% -$2.54K ﹤0.01% 673
2022
Q2
$35K Buy
17,212
+1,988
+13% +$4.34K ﹤0.01% 723
2022
Q1
$45K Buy
15,224
+51
+0.3% +$192 ﹤0.01% 661
2021
Q4
$68K Sell
15,173
-2,000
-12% -$9.49K ﹤0.01% 654
2021
Q3
$85K Buy
17,173
+3,329
+24% +$18.3K ﹤0.01% 644
2021
Q2
$94K Sell
13,844
-137
-1% -$1.11K ﹤0.01% 623
2021
Q1
$96K Sell
13,981
-8,218
-37% -$59.2K ﹤0.01% 640
2020
Q4
$138K Sell
22,199
-3,235
-13% -$19K ﹤0.01% 589
2020
Q3
$140K Buy
25,434
+12,864
+102% +$63.7K ﹤0.01% 593
2020
Q2
$64K Buy
+12,570
New +$55.8K ﹤0.01% 589

Other funds holding PRTK